US Tech 100

19,636.04

0.55%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

DXCM DexCom Inc

73.50

-6.01 (-7.56%)

Mar 07 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Feb 2025 to Mar 2025

DexCom (NASDAQ:DXCM)
Historical Stock Chart
From Mar 2024 to Mar 2025

DexCom Inc News

Form 8-K - Current report
Friday 7 March 2025 (10 hours ago) • Edgar (US Regulatory)

Dexcom Announces Upcoming Conference Presentation
Thursday 27 February 2025 (1 week ago) • Business Wire

Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors
Tuesday 25 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Tuesday 18 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 13 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results
Thursday 13 February 2025 (3 weeks ago) • Business Wire

DEXCOM STABILISCE UNA PRESENZA DIRETTA IN ITALIA
Wednesday 5 February 2025 (1 month ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 30 January 2025 (1 month ago) • Edgar (US Regulatory)

Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time.
Thursday 30 January 2025 (1 month ago) • Business Wire

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

DXCM DexCom Inc

DexCom Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

DXCM DexCom Inc

DexCom Inc News

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free